Publications

Evaluation of the Aspyre Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites

Aspyre Clinical Test for Lung: validation of a simple, fast and robust method for molecular profiling of actionable variants in plasma

Development of a machine learning model for Aspyre Lung (Blood): a new assay for rapid detection of actionable variants from plasma in NSCLC patients

Aspyre® Lung: validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissue

Aspyre® Lung: Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissue

Deployment of Aspyre® Lung targeted variant panel across three sites and testing with FFPE tissue and cytology-derived nucleic acid samples

Aspyre® Lung addresses critical gaps in NGS-based biomarker testing: robust variant calling from NGS QC fails

Validation of a simple, fast and robust novel method for complex genomic analysis of actionable NSCLC variants in tissue and plasma

Ultra-sensitive molecular detection of gene fusions from RNA using Aspyre®

Ultra-sensitive molecular detection of gene fusions from RNA using Aspyre®

Low-cost, simple and rapid assay for single-molecule detection of gene fusions from RNA with Aspyre®

External user testing of Biofidelity’s Aspyre® Lung assay demonstrates breakthrough capabilities and ease of use

Single-copy detection of somatic variants from solid and liquid biopsy